The Blood-Brain Barrier in the Human Glioma

Blood-Spinal Cord and Brain Barriers in Health and Disease

Volumn , Issue , 2003, Pages 561-576

  Eggstein, Gesa Rascher ^a   Liebner, Stefan ^b   Wolburg, Hartwig ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Blood brain barrier; Extracellular matrix; Glioma; Tight junction

Indexed keywords

EID: 84942849292     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012639011-7/50031-0     Document Type: Chapter

References (199)

1. Aaku-Saraste E., Hellwig A., Huttner W.B. Loss of occludin and functional tight junctions, but not ZO-1, during neural tube closure: Remodeling of the neuroepithelium prior to neurogenesis. Dev. Biol. 1996, 180:664-679.
2. Abbott N.J., Revest P.A. Control of brain endothelial permeability. Cerebrovasc. Brain Metab. Rev. 1991, 3:39-72.
3. Anderson J.M. MAGUK magic. Curr. Biol. 1997, 6:382-384.
4. Arenberg D.A., Kunkel S.L., Polverini P.J., Glass M., Burdick M.D., Strieter R.M. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J. Clin. Invest. 1996, 97:2792-2802.
5. Arthur F.E., Shivers R.R., Bowman P.D. Astrocyte-mediated induction of tight junctions in brain capillary endothelium: An efficient in vitro model. Dev. Brain Res. 1987, 36:155-159.
6. Auguste P., Gursel D.B., Lemiere S., Reimers D., Cuevas P., Carceller F., Di Santo J.P., Bikfalvi A. Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth both angiogenesis-dependent and-independent mechanisms. Cancer Res. 2001, 61:1717-1726.
7. Aurrand-Lions M.A., Duncan L., Du Pasquier L., Imhof B.A. Cloning of JAM-2 and JAM-3: An emerging junctional adhesion molecular family?. Curr. Top. Microbiol. Immunol. 2000, 251:91-98.
8. Balabanov R., Dore-Duffy P. Role of the CNS microvascular pericyte in the blood-brain barrier. J. Neurosci. Res. 1998, 53:637-644.
9. Balda M.S., Gonzales-Mariscal L., Matter K., Cereijido M., Anderson J.M. Assembly of tight junction: The role of diacylglycero. J. Cell Biol. 1993, 123:293-302.
10. Barber A.J., Lieth E. Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier. Dev. Dyn. 1997, 208:62-74.
11. Bates D.O., Lodwick D., Williams B. Vascular endothelial growth factor and microvascular permeability. Microcirculation 1999, 6:83-96.
12. Bauer H.C., Bauer H. Neural induction of the blood-brain barrier: Still an enigma. Cell. Mol. Neurobiol. 2000, 20:13-28.
13. Bazzoni G., Martinez-Estrada O.M., Orsenigo F., Cordenonsi M., Citi S., Dejana E. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. J. Biol. Chem. 2000, 275:20520-20526.
14. Bertossi M., Virgintino D., Maiorano E., Occhiogrosso M., Roncali L. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct. Pathol. 1997, 21:41-49.
15. Berzin T.M., Zipser B.D., Rafii M.S., Kuo-Leblanc V., Yancopoulos G.D., Glass D.J., Fallon J.R., Stopa E.G. Agrin and microvascular damage in Alzheimer's disease. Neurobiol. Aging 2000, 21:349-355.
16. Blake D.J., Kröger S. The neurobiology of Duchenne muscular dystrophy: Learning lessons from muscle. Trends Neurosci. 2000, 23:92-99.
17. Boettner B., Govek E.E., Cross J., Van Aelst L. The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin. Proc. Natl. Acad. Sci. USA 2000, 97:9064-9069.
18. Bornfeldt K.E., Raines E.W., Graves L.M., Skinner M.P., Krebs E.G., Ross R. Platelet-derived growth factor: Distinct signal transduction pathways associated with migration versus proliferation. Ann. N.Y. Acad. Sci. 1995, 766:416-430.
19. Brem S., Cotran R., Folkman J. Tumor angiogenesis: A quantitative method for histological grading. J. Natl. Cancer Inst. 1972, 48:347-356.
20. Brightman M.W., Reese T.S. Junctions between intimately apposed cell membranes in the vertebrate brain. J. Cell Biol. 1969, 40:648-677.
21. Burgess R.W., Skarnes W.C., Sanes J.R. Agrin isoforms with distinct amino termini. Differential expression, localization, and function. J. Cell Biol. 2000, 151:41-52.
22. Bussolino F., Camussi G., Baglioni C. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J. Biol. Chem. 1988, 263:11856-11861.
23. Camussi G., Turello E., Bussolino F., Baglioni C. Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Int. Arch. Allergy Appl. Immunol. 1991, 96:84-91.
24. Cheng N., Chen J. Tumor necrosis factor-α induction of endothelial ephrin A1 expression is mediated by a p38 MAPK-and SAPK/JNK-dependent but nuclear factor-γB-independent mechanism. J. Biol. Chem. 2001, 276:13771-13777.
25. Chiu A.Y., Espinosa de los Monteros A., Cole R.A., Loera S., de Vellis J. Laminin and s-laminin are produced and released by astrocytes, Schwann cells, and schwannomas in culture. Glia 1991, 4:11-24.
26. Chlenski A., Ketels K.V., Engeriser J.L., Talamonti M.S., Tsao M.S., Koutnikova H., Oyasu R., Scarpelli D.G. zo-2 gene alternative promoters in normal and neoplastic human pancreatic duct cells. Int. J. Cancer 1999, 83:349-358.
27. Chlenski A., Ketels K.V., Korovaitseva H., Talamonti M.S., Oyasu R., Scarpelli D.G. Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues. Biochim. Biophys. Acta 2000, 1493:319-324.
28. Chlenski A., Ketels K.V., Tsao M.S., Talamonti M.S., Anderson M.R., Oyasu R., Scarpelli D.G. Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinoma. Int. J. Cancer 1999, 82:137-144.
29. Citi S., Denisenko N. Phosphorylation of the tight junction protein cingulin and the effects of protein kinase inhibitors and activators in MDCK epithelial cells. J. Cell Sci. 1995, 108:2917-2926.
30. Citi S., Sabanay H., Jakes R., Geiger B., Kendrick-Jones J. Cingulin, a new peripheral component of tight junctions. Nature 1988, 333:272-276.
31. Citi S., Sabanay H., Kendrick-Jones J., Geiger B. Cingulin: Characterization and localization. J. Cell Sci. 1989, 93:107-122.
32. Claude P. Morphologic factors influencing transepithelial permeability: A model for the resistance of the zonula occludens. J. Membr. Biol. 1978, 39:219-232.
33. Claude P., Goodenough D.A. Fracture faces of zonulae occludentes from "tight" and "leaky" epithelia. J. Cell Biol. 1973, 58:390-400.
34. Cordenonsi M., D'Atri F., Hammar E., Parry D.A., Kendrick-Jones J., Shore D., Citi S. Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J. Cell Biol. 1999, 147:1569-1582.
35. Cunningham S.A., Arrate M.P., Rodriguez J.M., Bjercke R.J., Vanderslice P., Morris A.P., Brock T.A. A novel protein with homology to the junctional adhesion molecule: Characterization of leukocyte interactions. J. Biol. Chem. 2000, 275:34750-34756.
36. Damert A., Machein M., Breier G., Fujita M.Q., Hanahan D., Risau W., Plate K.H. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanosms. Cancer Res. 1997, 57:3860-3864.
37. Denisenko N., Burighel P., Citi S. Different effects of protein kinase inhibitors on the localization of junctional proteins at cell-cell contact sites. J. Cell Sci. 1994, 107:969-981.
38. Denker B.M., Nigam S.K. Molecular structure and assembly of the tight junction. Am. J. Physiol. 1998, 274:F1-F9.
39. Desbaillets I., Diserens A.C., Tribolet N., Hamou M.F., Van Meir E.G. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J. Exp. Med. 1997, 186:1201-1212.
40. Desbaillets I., Diserens A.C., de Tribolet N., Hamou M.F., Van Meir E.G. Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma. Oncogene 1999, 18:1447-1456.
41. Dinda A.K., Sarkar C., Roy S., Kharbanda K., Mathur M., Khosla A.K., Banerji A.K. A transmission and scanning electron microscopic study of tumoral and peritumoral microblood vessels in human gliomas. J. Neurooncol. 1993, 16:149-158.
42. Ding H., Roncari L., Wu X., Lau N., Shannon P., Nagy A., Guha A. Expression and hypoxic regulation of angiopoietins in human astrocytomas. Neuro-oncology 2001, 3:1-10.
43. Dobrogowska D.H., Lossinsky A.S., Tarnawski M., Vorbrodt A.W. Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J. Neurocytol. 1998, 27:163-173.
44. Eberle K., Oberpichler A., Trantakis C., Krupp W., Knupfer M., Tschesche H., Seifert V. The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells. Anticancer Res. 2000, 20:1679-1684.
45. Ebnet K., Schulz C.U., Meyer Zu Brickwedde M.K., Pendl G.G., Vestweber D. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J. Biol. Chem. 2000, 275:27979-27988.
46. Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., Collins V.P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 1991, 51:2164-2172.
47. Esser S., Wolburg K., Wolburg H., Breier G., Kurzchalia T., Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 1998, 140:947-959.
48. Forsyth P.A., Wong H., Laing T.D., Rewcastle N.B., Morris D.G., Muzik H., Leco K.J., Johnston R.N., Brasher P.M., Sutherland G., Edwards D.R. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br. J. Cancer 1999, 79:1828-1835.
49. Frigeri A., Nicchia G.P., Nico B., Quondamatteo F., Herken R., Roncali L., Svelto M. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice. FASEB J. 2001, 15:90-98.
50. Fujimoto K. Freeze-fracture replica electron microscopy combined with SDS digestion for cytochemical labeling of integral membrane proteins: Application to the immunogold labeling of intercellular junctional complexes. J. Cell Sci. 1995, 108:3443-3449.
51. Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S.H. Claudin-1 and -2: Novel integral membrane proteines localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998, 141:1539-1550.
52. Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S. Occludin: A novel integral membrane protein localizing at tight junctions. J. Cell Biol. 1993, 123:1777-1788.
53. Furuse M., Itoh M., Hirase T., Nagafuchi A., Yonemura S., Tsukita S. Direct association of occuludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell Biol. 1994, 127:1617-1626.
54. Furuse M., Sasaki H., Fujimoto K., Tsukita S.H. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J. Cell Biol. 1998, 143:391-401.
55. Furuse M., Sasaki H., Tsukita S. Manner of interaction of heterogenous claudin species within and between tight junction strands. J. Cell Biol. 1990, 147:891-903.
56. Gee S.H., Montanaro F., Lindenbaum M.H., Carbonetto S. Dystroglycan-α, a dystrophin-associated glyoprotein, is a functional agrin receptor. Cell 1994, 77:675-686.
57. Giepmans B.N.G., Moolenaar W.H. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr. Biol. 1998, 8:931-934.
58. Giraudo E., Primo L., Audero E., Gerber H.P., Koolwijk P., Soker S., Klagsbrun M., Ferrara N., Bussolino F. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem. 1998, 273:22128-22135.
59. Gladson C.L. Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J. Neuropathol. Exp. Neurol. 1996, 55:1143-1149.
60. Gloor S.M., Wachtel M., Bolliger M.F., Ishihara H., Landmann R., Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Res. Rev. 2001, 36:258-264.
61. Goldman C.K., Kim J., Wong W.L., King V., Brock T., Gillespie G.Y. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell 1993, 4:121-133.
62. Groft L.L., Muzik H., Rewcastle N.B., Johnston R.N., Knauper V., Lafleur M.A., Forsyth P.A., Edwards D.R. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Br. J. Cancer 2001, 85:55-63.
63. Gumbiner B., Simons K. A functional assay for proteins involved in establishing an epithelial occluding barrier: Identification of an uvomorulin-like polypeptide. J. Cell Biol. 1986, 102:457-468.
64. Gumbiner B., Stevenson B., Grimaldi A. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J. Cell Biol. 1988, 107:1575-1587.
65. Guo D.Q., Wu L.W., Dunbar J.D., Ozes O.N., Mayo L.D., Kessler K.M., Gustin J.A., Baerwald M.R., Jaffe E.A., Warren R.S., Donner D.B. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. J. Biol. Chem. 2000, 275:11216-11221.
66. Guretzki H.J., Schleicher E., Gerbitz K.D., Olgemoller B. Heparin induces endothelial extracellular matrix alterations and barrier dysfunction. Am. J. Physiol. 1994, 267:C946-C954.
67. Hamasuna R., Kataoka H., Moriyama T., Itoh H., Seiki M., Koono M. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int. J. Cancer 1999, 82:274-281.
68. Han Y.P., Tuan T.L., Wu H., Hughes M., Garner W.L. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J. Cell Sci. 2001, 114:131-139.
69. Haskins J., Gu L., Wittchen E.S., Hibbard J., Stevenson B.R. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J. Cell Biol. 1998, 141:199-208.
70. Hayashi Y., Nomura M., Yamagishi S., Harada S., Yamashita J., Yamamoto H. Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes. Glia 1997, 19:13-26.
71. Hermanson M., Funa K., Hartman M., Claesson-Welsh L., Heldin C.H., Westermark B., Nister M. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 1992, 52:3213-3219.
72. Higuchi M., Ohnishi T., Arita N., Hiraga S., Hayakawa T. Expression of tenascin human gliomas: Its relation to histological malignancy, tumor defifferentiation and angiogenesis. Acta Neuropathol. 1993, 85:481-487.
73. Hirano A., Matsui T. Vascular structures in brain tumors. Hum. Pathol. 1975, 141:199-208.
74. Hirase T., Staddon J.M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S., Rubin L.L. Occludin as a possible determinant of tight junction permeability in ECs. J. Cell Sci. 1997, 110:1603-1613.
75. Hirata K.-I., Ishida T., Penta K., Rezaee M., Yang E., Wohlgemuth J., Quertermous T. Cloning of an immunoglobulin familiy adhesion molecule selecteively expressed by endothelial cells. J. Biol. Chem. 2001, 276:16223-16231.
76. Horuk R., Martin A., Hesselgesser J., Hadley T., Lu Z.U., Wang Z.W., Peiper S.C. The Duffy antigen receptor for chemokines: Structural analysis and expression in the brain. J. Leukocyte Biol. 1996, 59:29-38.
77. Howarth A.G., Hughes M.R., Stevenson B.R. Detection of the tight junction associated protein ZO-1 in astrocytes and other non-epithelial cell types. Am. J. Physiol. 1992, 262:C461-C469.
78. Hunter D.D., Llinas R., Ard M., Merlie J.P., Sanes J.R. Expression of s-laminin and laminin in the developing rat central nervous system. J. Comp. Neurol. 1992, 323:238-251.
79. Imamura M., Ozawa E. Differential expression of dystrophin isoforms and utrophin during dibutyryl-cAMP-induced morphological differentiation of rat brain astrocytes. Proc. Natl. Acad. Sci. USA 1998, 95:6139-6144.
80. Itoh M., Nagafuchi A., Yonemura S., Kitaniyasuda T., Tsukita S. The 220 kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction associated protein in epithelial cells -cDNA cloning and immunoelectron microscpy. J. Cell Biol. 1993, 121:491-502.
81. Itoh M., Furuse M., Morita K., Kubota K., Saitou M., Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2 and ZO-3, with the COOH termini of claudins. J. Cell Biol. 1999, 147:1351-1363.
82. Itoh M., Morita K., Tsukita S. Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and alpha catenin. J. Biol. Chem. 1999, 274:5981-5986.
83. Itoh M., Nagafuchi A., Moroi S., Tsukita S. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to a-catenin and actin filaments. J. Cell Biol. 1997, 138:181-192.
84. Janzer R.C., Raff M.C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987, 325:253-257.
85. Jesaitis L.A., Goodenough D.A. Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein. J. Cell Biol. 1994, 124:949-962.
86. Kachra Z., Beaulieu E., Delbecchi L., Mousseau N., Berthelet F., Moumdjian R., Del Maestro R., Beliveau R. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin. Exp. Metastasis 1999, 17:555-566.
87. Ke C., Poon W.S., Ng.H.K., Pang J.C., Chan Y. Heterogeneous responses of aquaporin-4 in oedema formation in a replicated severe traumatic brain injury model in rats. Neurosci. Lett. 2001, 301:21-24.
88. Kim I., Kim J.H., Ryu Y.S., Liu M., Koh G.Y. Tumor necrosis factor-alpha upregulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2000, 269:361-365.
89. Kniesel U., Risau W., Wolburg H. Development of blood-brain barrier tight junctions in the rat cortex. Dev. Brain Res. 1996, 96:229-240.
90. Kniesel U., Wolburg H. The tight junctions of the blood-brain barrier. Cell. Mol. Neurobiol. 2000, 20:57-76.
91. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., Di Pietro L.A., Elner V.M., Elner S.G., Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
92. Koochekpour S., Merzak A., Pilkington G.J. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett. 1996, 102:209-215.
93. Lamszus K., Laterra J., Westphal M., Rosen E.M. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int. J. Dev Neurosci. 1999, 17:517-530.
94. Lamszus K., Schmidt N.O., Jin L., Laterra J., Zagzag D., Way D., Witte M., Weinand M., Goldberg I.D., Westphal M., Rosen E.M. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int. J. Cancer 1998, 75:19-28.
95. Landau B.J., Kwaan H.C., Verrusio E.N., Brem S.S. Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors. Cancer Res. 1994, 54:1105-1108.
96. Leibovich S.J., Polverini P.J., Shepard H.M., Wiseman D.M., Shively V., Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987, 329:630-632.
97. Liang T.W., DeMarco R.A., Mrsny R.J., Gurney A., Gray A., Hooley J., Aaron H.L., Huang A., Klassen T., Tumas D.B., Fong S. Characterization of huJAM: Evidence for involvement in cell-cell contact and tight junction regulation. Am. J. Physiol. Cell Physiol. 2000, 279:C1733-C1743.
98. Liebner S., Fischmann A., Rascher G., Duffner F., Grote E.H., Kalbacher H., Wolburg H. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. 2000, 100:323-331.
99. Liebner S., Kniesel U., Kalbacher H., Wolburg H. Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur. J. Cell Biol. 2000, 79:707-717.
100. Lippoldt A., Liebner S., Andbjer B., Kalbacher H., Wolburg H., Haller H., Fuxe K. Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expressions by protein kinase. C. Neuroreport 2000, 11:1427-1431.
101. Liu Y., Nusral A., Schnell F.J., Reaves T.A., Walsh S., Pochet M., Parkos C.A. Human junction adhesion molecule regulates tight junction resealing in epithelia. J. Cell Sci. 2000, 113:2363-23674.
102. Machein M.R., Kullmer J., Fiebich B.L., Plate K.H., Warnke P.C. Vascular endothelial growth factor expression, vascular volume, and, capillary permeability in human brain tumors. Neurosurgery 1999, 44:732-740. discussion 740-741.
103. Maeshima Y., Yerramalla U.L., Dhanabal M., Holthaus K.A., Barbashov S., Kharbanda S., Reimer C., Manfredi M., Dickerson W.M., Kalluri R. Extracellular matrix derived peptide binds to alphavbeta3 integrin and inhibits angiogenesis. J. Biol. Chem. 2001.
104. Mandriota S.J., Pepper M.S. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J. Cell Sci. 1997, 110:2293-2302.
105. Manley G.T., Fujimura M., Ma T., Noshita N., Fliz F., Bollen A.W., Chan P., Verkman A.S. Aquaporin-4-deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nature Med. 2000, 6:159-163.
106. Marcial M.A., Carlson S.L., Madara J.L. Partitioning of paracellular conductance along the ileal crypt-villus axis: A hypothesis based on structural analysis with detailed consideration of tight junction structure-function relationship. J. Membr. Biol. 1984, 80:59-70.
107. Martin-Padura I., Lostaglio S., Schneemann M., Williams L., Romano M., Fruscella P., Panzeri C., Stoppaciaro A., Ruco L., Villa A., Simmons D., Dejana E. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J. Cell Biol. 1998, 142:117-127.
108. Mazar A.P., Henkin J., Goldfarb R.H. The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis. Angiogenesis 1999, 3:15-32.
109. McMahan U.J. The agrin hypothesis. Cold Spring Harb. Symp. Quant. Biol. 1990, 55:407-418.
110. Meager A. Bioimmunoassays for proinflammatory cytokines involving cytokine-induced cellular adhesion molecule expression in human glioblastoma cell lines. J. Immunol. Methods 1996, 190:235-244.
111. Mikkelsen T., Yan P.S., Ho K.L., Sameni M., Sloane B.F., Rosenblum M.L. Immunolocalization of cathepsin B in human glioma: Implications for tumor invasion and angiogenesis. J. Neurosurg. 1995, 83:285-290.
112. Min H.Y., Doyle L.V., Vitt C.R., Zandonella C.L., Stratton-Thomas J.R., Shuman M.A., Rosenberg S. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res. 1996, 56:2428-2433.
113. Mishima K., Higashiyama S., Asai A., Yamaoka K., Nagashima Y., Taniguchi N., Kitanaka C., Kirino T., Kuchino Y. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol. 1998, 96:322-328.
114. Miyamon H., Takino T., Kobayashi Y., Tokai H., Itoh Y., Seiki M., Sato H. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J. Biol. Chem. 2001, 276:28204-28211.
115. Mizuguchi H., Utoguchi N., Mayumi T. Preparation of glial extracellular matrix: A novel method to analyze glial-endothelial cell interaction. Brain Res. Brain Res. Protoc. 1997, 1:339-343.
116. Morita K., Furuse M., Fujimoto K., Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. USA 1999, 96:511-516.
117. Morita K., Sasaki H., Fujimoto K., Furuse M., Tsukita S. Claudin-11/OSP-based tight junctions of myelin sheaths in brain and Sertoli cells in testis. J. Cell Biol. 1999, 145:579-588.
118. Morita K., Sasaki H., Furuse M., Tsukita S. Endothelial claudin claudin-5/tmvcf constitutes tight junction strands in endothelial cells. J. Cell Biol. 1999, 147:185-194.
119. Moriyama T., Kataoka H., Koono M., Wakisaka S. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: Evidence for a role in progression of astrocytic tumors. Int. J. Mol. Med. 1999, 3:531-536.
120. Nag S. Protective effect of flunarizine on blood-brain barrier permeability alterations in acutely hypertensive rats. Stroke 1991, 22:1265-1269.
121. Nagy Z., Peters H., Hüttner I. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab. Invest. 1984, 50:313-322.
122. Nasdala L., Wolburg-Buchholz K., Wolburg H., Kuhn A., Ebnet K., Brachtendorf T., Samulowitz U., Kuster B., Engelhardt B., Vestweber D., Butz S. A transmembrane tight junction protein selectively expressed on endothelial cells and platelets. J. Biol. Chem. 2002, 277:16294-16303.
123. Neely J.D., Amiry-Moghaddam M., Ottersen O.P., Froehner S.C., Agre P., Adams M.E. Syntrophin-deprendent expression and localization of aquaporin-4 water channel protein. Proc. Natl. Acad. Sci. USA 2001, 98:14108-14113.
124. Nelson A.R., Fingleton B., Rothenberg M.L., Matrisian L.M. Matrix metalloproteinases: Biologic activity and clinical implications. J. Clin. Oncol. 2000, 18:1135-1149.
125. Neuhaus J. Orthogonal arrays of particles in astroglial cells: Quantitative analysis of their density, size, and correlation with intramembranous particles. Glia 1990, 3:241-251.
126. Nico B., Frigeri A., Nicchia G.P., Quondamatteo F., Herken R., Errede M., Ribatti D., Svelto M., Roncali L. Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier. J. Cell Sci. 2001, 114:1297-1307.
127. Niedbala M.J., Stein M. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells. Biomed. Biochim. Acta 1991, 50:427-436.
128. Niida H., Takeuchi S., Tanaka R., Minakawa T. Angiogenesis in microvascular endothelial cells induced by glioma cells and inhibited by tumor necrosis factor in vitro. Neurol. Med. Chir. 1995, 35:209-214.
129. Nitkin R.M., Smith M.A., Magill C., Fallon J.R., Yao Y.M., Wallace B.G., McMahan U.J. Identification of agrin, a synaptic organizing protein from Torpedo electric organ. J. Cell Biol. 1987, 105:2471-2478.
130. Papadopoulos M.C., Saadoun S., Davies D.C., Bell B.A. Emerging molecular mechanism of brain tumor oedema. Br. J. Neurosurg. 2001, 15:101-108.
131. Pasternak C., Wong S., Elson E.L. Mechanical function of dystrophin in muscle cells. J. Cell Biol. 1995, 128:355-361.
132. Peters A., Palay S.L., Webster H. The Fine Structure of the Nervous System 1991, Oxford University Press, New York. 3rd Ed.
133. Plate K.H., Breier G., Farrell C.L., Risau W. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab. Invest. 1992, 67:529-534.
134. Plate K.H., Risau W. Angiogenesis in malignant gliomas. Glia 1995, 15:339-347.
135. Platten M., Wick W., Weller M. Malignant glioma biology: Role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc. Res. Tech. 2001, 52:401-410.
136. Platten M., Wick W., Wild-Bode C., Aulwurm S., Dichgans J., Weller M. Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via up-regulation of alpha (V)beta(3) integrin expression. Biochem. Biophys. Res. Commun. 2000, 268:607-611.
137. Polette M., Birembaut P. Membrane-type metalloproteinases in tumor invasion. Int. J. Biochem. Cell Biol. 1998, 30:1195-1202.
138. Raithatha S.A., Muzik H., Muzik H., Rewcastle N.B., Johnston R.N., Edwards D.R., Forsyth P.A. Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro-oncology 2000, 2:145-150.
139. Rajasekaran A.K., Hojo M., Huima T., Rodriguez-Boulan E. Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. J. Cell Biol. 1996, 132:451-464.
140. Rascher G., Fischmann A., Kröger S., Duffner F., Grote E.-H., Wolburg H. Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: Spatial segregation of tenascin and agrin. Acta Neuropathol. 2002, 104:85-91.
141. Reese T.S., Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 1967, 34:207-217.
142. Revest P.A., Abbott N.J., Gillespie J.I. Receptor-mediated changes in intracellular [Ca2+] in cultured rat brain capillary endothelial cells. Brain Res. 1991, 549:159-161.
143. Roessler K., Suchanek G., Breitschopf H., Kitz K., Matula C., Lassmann H., Koos W.T. Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: Comparison of immunohistochemistry with in situ hybridization using molecular probes. J. Neurosurg. 1995, 83:291-297.
144. Rojiani A.M., Dorovini-Zis K. Glomeruloid vascular structures in glioblastoma multiforme: An immunohistochemical and ultrastructural study. J. Neurosurg. 1996, 85:1078-1084.
145. Rosenberg G.A., Estrada E., Kelley R.O., Kornfeld M. Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat. Neurosci. Lett. 1993, 160:117-119.
146. Rubin L.L., Hall D.E., Porter S., Barbu K., Cannon C., Horner H.C., Janatpour M., Liaw C.W., Manning K., Morales J., Tanner L.J., Tomaselli K.J., Bard F. A cell culture model of the blood-brain barrier. J. Cell Biol. 1991, 115:1725-1736.
147. Ryuto M., Ono M., Izumi H., Yoshida S., Weich H.A., Kohno K., Kuwano M. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells Possible roles of SP-1. J. Biol. Chem. 1996, 271:28220.
148. Saadoun S., Papadopoulos M.C., Davies D.C., Krishna S., Bell B.A. Aquaporin-4 expression is increased in oedematous human brain tumours. J. Neurol. Neurosurg. Psychiat. 2002, 72:262-265.
149. Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Inazawa J., Fujimoto K., Tsukita S. Mammalian occludin in epithelial cells: Its expression and subcellular distribution. Eur. J. Cell Biol. 1997, 73:222-231.
150. Saitou M., Fujimoto K., Doi Y., Fujimoto T., Furuse M., Takano H., Noda T., Tsukita S. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J. Cell Biol. 1998, 141:397-408.
151. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell. 2000, 11:4131-4142.
152. Sameshima T., Nabeshima K., Toole B.P., Yokogami K., Okada Y., Goya T., Koono M., Wakisaka S. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int. J. Cancer 2000, 88:21-27.
153. Sameshima T., Nabeshima K., Toole B.P., Yokogami K., Okada Y., Goya T., Koono M., Wakisaka S. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in cocultures with brain-derived fibroblasts. Cancer Lett. 2000, 157:177-184.
154. Sanes J.R., Engvall E., Butkowski R., Hunter D.D. Molecular heterogeneity of basal laminae: Isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J. Cell Biol. 1990, 111:1685-1699.
155. Satoh H., Zhong Y., Isomura H., Saitoh M., Enomoto K., Sawada N., Mori M. Localization of 7H6 tight junction-associated antigen along the cell border of vascular ECs correlates with paracellular barrier function against ions large molecules, and cancer cells. Exp Cell Res. 1996, 222:269-274.
156. Savettieri G., Di Liegro I., Catania C., Licata L., Pitarresi G.L., D'Agostino S., Schiera G., De Caro V., Giandalia G., Giannola L.I., Cestelli A. Neurons and ECM regulate occludin localization in brain endothelial cells. Neuroreport 2000, 11:1081-1084.
157. Saxena A., Ali I.U. Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines. Oncogene 1992, 7:243-247.
158. Schmidt N.O., Westphal M., Hagel C., Ergun S., Stavrou D., Rosen E.M., Lamszus K. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int. J. Cancer. 1999, 84:10-18.
159. Schreiber A.B., Winkler M.E., Derynck R. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science 1986, 232:1250-1253.
160. Sobocka M.B., Sobocki T., Banerjee P., Weiss C., Rushbrook J.I., Norin A.J., Hartwig J., Salifu M.O., Markell M.S., Babinska A., Ehrlich Y.H., Kornecki E. Cloning of the human platelet F11 receptor: A cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation. Blood 2000, 95:2600-2609.
161. Stefanik D.F., Rizkalla L.R., Soi A., Goldblatt S.A., Rizkalla W.M. Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res. 1991, 51:5760-5765.
162. Stevenson B.R., Siliciano J.D., Mooseker M.S., Goodenough D.A. Identification of ZO-1: A high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J. Cell Biol. 1986, 103:755-766.
163. Stevenson B.R., Anderson J.M., Goodenough D.A., Mooseker M.S. Tight junction structure and ZO-1 content are identical in two strains of Madin-Darby canine kidney cells. J. Cell Biol. 1988, 107:2401-2408.
164. Stiles J.D., Ostrow P.T., Balos L.L., Greenberg S.J., Plunkett R., Grand W., Heffner R.R. Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J. Neuropathol. Exp. Neurol. 1997, 56:435-439.
165. Stone D.M., Nikolics K. Tissue- and age-specific expression patterns of alternatively spliced agrin mRNA transcripts in embryonic rat suggest novel developmental roles. J. Neurosci. 1995, 15:6767-6778.
166. Takano S., Yoshii Y., Kondo S., Suzuki H., Maruno T., Shirai S., Nose T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 1996, 56:2185-2190.
167. Tamaki M., McDonald W., Del Maestro R.F. The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells. J. Neurooncol. 1998, 39:205-216.
168. Tilling T., Korte D., Hoheisel D., Galla H.J. Basement membrane proteins influence brain capillary endothelial barrier function in vitro. J. Neurochem. 1998, 71:1151-1157.
169. Tontsch U., Bauer H.C. Glial cells and neurons induce blood brain barrier related enzymes in cultured cerebral ECs. Brain Res. 1991, 539:247-253.
170. Tsai J.C., Goldman C.K., Gillespie G.Y. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB, and bFGF. J. Neurosurg. 1995, 82:864-873.
171. Tsen G., Napier A., Halfter W., Cole G.J. Identification of a novel alternatively spliced agrin mRNA that is preferentally expressed in non-neural cells. J. Biol. Chem. 1995, 270:15934-15937.
172. Uhrbom L., Hesselager G., Nister M., Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 1998, 58:5275-5279.
173. Van Deurs B., Koehler J.K. Tight junctions in the choroid plexus epithelium: A freeze-fracture study including complementary replicas. J. Cell Biol. 1979, 80:662-673.
174. Van Itallie C.M., Anderson J.M. Occludin confers adhesiveness when expressed in fibroblasts. J. Cell Sci. 1997, 110:1113-1121.
175. Van Mayr E.G. Cytokines and tumors of the central nervous system. Glia 1995, 15:264-288.
176. Venero J.L., Vizuete M.L., Machado A., Cano J. Aquaporins in the central nervous system. Progr. Neurobiol. 2001, 63:321-336.
177. Virgintino D., Maiorano E., Errede M., Vimercati A., Greco P., Selvaggi L., Roncali L., Bertossi M. Astroglia-microvessel relationship in the developing human telencephalon. Int. J. Dev. Biol. 1998, 42:1165-1168.
178. Vizuete M.L., Venero J.L., Vargas C., Ilundain A.A., Echevarria M., Machado A., Cano J. Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury. Potential role in brain edema. Neurobiol. Dis. 1999, 6:245-258.
179. Wang D., Huang H.J., Kazlauskas A., Cavenee W.K. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res. 1999, 59:1464-1472.
180. Wang H., Kaiser J.A. Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem. Biophys. Res. Commun. 2000, 272:900-905.
181. Whitelock J.M., Murdoch A.D., Iozzo R.V., Underwood P.A. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparinases. J. Biol. Chem. 1996, 271:10079-10086.
182. Wiedlocha A. Following angiogenin during angiogenesis: A journey from the cell surface to the nucleolus. Arch. Immunol. Ther. Exp. 1999, 47:299-305.
183. Williams L.A., Martin-Padura I., Dejana E., Hogg N., Simmons D.L. Identification and characterisation of human junctional adhesion molecule (JAM). Mol. Immunol. 1999, 36:1175-1188.
184. Willott E., Balda M.S., Fanning A.S., Jameson B., Vanltallie C., Anderson J.M. The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. Proc. Natl. Acad. Sci. USA 1993, 90:7834-7838.
185. Wolburg H. Orthogonal arrays of intramembranous particles: A review with special reference to astrocytes. J. Brain Res. 1995, 36:239-258.
186. Wolburg H., Lippoldt A. Tight Junctions of the blood-brain barrier: Development, composition, and regulation. Gen. Pharmacol. Vasc. Syst. 2002, 38:323-337.
187. Wolburg H., Neuhaus J., Kniesel U., Krauss B., Schmid E.M., Ocalan M., Farrell C., Risau W. Modulation of tight junction structure in blood-brain barrier endothelial cells: Effects of tissue culture, second messengers and cocultured astrocytes. J. Cell Sci. 1994, 107:1347-1357.
188. Wolburg H., Risau W. Formation of the blood-brain barrier. Neuroglia 1995, 763-776. Oxford University Press, New York. H. Kettenmann, B.R. Ransom (Eds.).
189. Wolburg H., Wolburg-Buchholz K., Liebner S., Engelhardt B. Claudin-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse. Neurosci. Lett. 2001, 307:77-80.
190. Woods D.F., Bryant P.J. The disc large tumor suppressor gene of Drosophila encodes a guanylate kinase homolog localized at septate junctions. Cell 1991, 66:451-464.
191. Xin X., Yang S., Ingle G., Zlot C., Rangell L., Kowalski J., Schwall R., Ferrara N., Gerritsen M.E. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am. J. Pathol. 2001, 158:1111-1120.
192. Yamada N., Kato M., Yamashita H., Nister M., Miyazono K., Heldin C.H., Funa K. Enhanced expression of transforming growth factor-beta and its type-1 and type-II receptors in human glioblastoma. Int. J. Cancer 1995, 62:386-392.
193. Yamagata K., Tagami M., Nara Y., Mitani M., Kubota A., Fujino H., Numano F., Kato T., Yamori Y. Astrocyte-conditioned medium induces blood-brain barrier properties in endothelial cells. Clin. Exp. Pharmacol. Physiol. 1997, 24:710-713.
194. Yamamoto T., Harada N., Kano K., Taya S., Canaani E., Matsuura Y., Mizoguchi A., Ide C., Kaibuchi K. The Ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells. J. Cell Biol. 1997, 139:785-795.
195. Yang E.Y., Moses H.L. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 1990, 111:731-741.
196. Yoshida S., Ono M., Shono T., Izumi H., Ishibashi T., Suzuki H., Kuwano M. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol. Cell. Biol. 1997, 17:4015-4023.
197. Zaccaria M.L., Di Tommaso F., Brancaccio A., Paggi P., Petrucci T.C. Dystroglycan distribution in adult mouse brain: A light and electron microscopy study. Neuroscience 2001, 104:311-324.
198. Zagzag D., Amirnovin R., Greco M.A., Yee H., Holash J., Wiegand S.J., Zabski S., Yancopoulos G.D., Grumet M. Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis. Lab. Invest. 2000, 80:837-849.
199. Zhong Y., Saitoh T., Minase T., Sawada N., Enomoto K., Mori M. Monoclonal antibody 7H6 reacts with a novel junction-associated protein distinct from ZO-1, cingulin and ZO-2. J. Cell Biol. 1993, 120:477-484.